Liver Cancer

Liver cancer treatments



Immunotherapies are designed to boost the body’s own immune system to help fight the cancer. One common type of immunotherapy is called an immune checkpoint inhibitor, which works by blocking the pathways that would otherwise allow the cancer to hide from the immune system.

Immunotherapies approved in Europe for use in HCC include atezolizumab in combination with bevacizumab, an anti-angiogenesis therapy.

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.